Myocardial thickening in oncology patients should prompt further imaging such as CMR to rule out metastasis before establishing a diagnosis like HCM.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to consider metastasis in oncology patients with HCM-like thickening; leaves open its true prevalence.
We present a patient who was on active surveillance for lung adenocarcinoma and hypertrophic septal cardiomyopathy (HCM), was referred for cardiac magnetic resonance (CMR) assessment for risk stratification due to HCM. CMR revealed a large myocardial metastasis obstructing mid-apical left and right ventricular cavity. Any wall thickening in oncology patients should prompt to perform further imaging before establishing certain diagnosis.
No takes yet. Share an insight, caveat, or question.
Topel et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: